Gene Page: TMSB15B
Summary ?
| GeneID | 286527 |
| Symbol | TMSB15B |
| Synonyms | Tbeta15b |
| Description | thymosin beta 15B |
| Reference | HGNC:HGNC:28612|Ensembl:ENSG00000158427|HPRD:17546|Vega:OTTHUMG00000022117 |
| Gene type | protein-coding |
| Map location | Xq22.2 |
| Sherlock p-value | 0.008 |
| eGene | Myers' cis & trans |
Gene in Data Sources
| Gene set name | Method of gene set | Description | Info |
|---|---|---|---|
| CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
eQTL annotation
| SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
|---|---|---|---|---|---|---|---|---|
| rs1890968 | chr1 | 76549622 | TMSB15B | 286527 | 0.08 | trans | ||
| rs2502827 | chr1 | 176044216 | TMSB15B | 286527 | 0.02 | trans | ||
| rs17022378 | chr1 | 206654057 | TMSB15B | 286527 | 0.03 | trans | ||
| rs12405921 | chr1 | 206695730 | TMSB15B | 286527 | 0.01 | trans | ||
| rs16829545 | chr2 | 151977407 | TMSB15B | 286527 | 5.711E-10 | trans | ||
| rs16841750 | chr2 | 158288461 | TMSB15B | 286527 | 0 | trans | ||
| rs7584986 | chr2 | 184111432 | TMSB15B | 286527 | 0.01 | trans | ||
| rs6729020 | chr2 | 189064719 | TMSB15B | 286527 | 0.14 | trans | ||
| rs9810143 | chr3 | 5060209 | TMSB15B | 286527 | 0.02 | trans | ||
| rs6821203 | chr4 | 189475342 | TMSB15B | 286527 | 0.11 | trans | ||
| rs7024600 | chr9 | 104610865 | TMSB15B | 286527 | 0.03 | trans | ||
| rs1629937 | chr14 | 77059671 | TMSB15B | 286527 | 0 | trans | ||
| rs17104720 | chr14 | 77127308 | TMSB15B | 286527 | 0 | trans | ||
| rs17104722 | chr14 | 77138109 | TMSB15B | 286527 | 0.02 | trans | ||
| rs17104782 | chr14 | 77156735 | TMSB15B | 286527 | 0.02 | trans | ||
| rs16955618 | chr15 | 29937543 | TMSB15B | 286527 | 1.72E-16 | trans | ||
| rs1041786 | chr21 | 22617710 | TMSB15B | 286527 | 0.02 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section V. Pathway annotation
| Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
|---|---|---|---|
| AMUNDSON RESPONSE TO ARSENITE | 217 | 143 | All SZGR 2.0 genes in this pathway |
| BUYTAERT PHOTODYNAMIC THERAPY STRESS DN | 637 | 377 | All SZGR 2.0 genes in this pathway |
| BENPORATH SUZ12 TARGETS | 1038 | 678 | All SZGR 2.0 genes in this pathway |
| SMID BREAST CANCER BASAL UP | 648 | 398 | All SZGR 2.0 genes in this pathway |
| HAN SATB1 TARGETS DN | 442 | 275 | All SZGR 2.0 genes in this pathway |
| JOHNSTONE PARVB TARGETS 3 DN | 918 | 550 | All SZGR 2.0 genes in this pathway |
| PEDERSEN METASTASIS BY ERBB2 ISOFORM 7 | 403 | 240 | All SZGR 2.0 genes in this pathway |
| KRIEG HYPOXIA NOT VIA KDM3A | 770 | 480 | All SZGR 2.0 genes in this pathway |